首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Current hematologic malignancy reports

缩写:CURR HEMATOL MALIG R

ISSN:1558-8211

e-ISSN:1558-822X

IF/分区:3.3/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引853
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Heather R Wolfe,Lindsay A M Rein Heather R Wolfe
Purpose of review: Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by uncontrolled proliferation of mature and maturing granulocytes. The disease is characterized by the presence of transloca...
Katia B Pagnano,Ana Ines Varela,Carolina Pavlovsky et al. Katia B Pagnano et al.
Purpose of review: Chronic myeloid leukemia (CML) management in developing countries has improved in the last years, but the availability of therapeutic resources, monitoring, reimbursement, and financial issues may be a ...
Nathalie Javidi-Sharifi,Gabriela Hobbs Nathalie Javidi-Sharifi
Purpose of review: This review will focus on recent and emerging treatment paradigms in chronic phase CML. The discussion of each novel treatment or drug combination will include a brief overview of scientific rational an...
Kelly L Schoenbeck,Kathryn E Flynn Kelly L Schoenbeck
Purpose of review: Tyrosine kinase inhibitors (TKIs) allow many patients with chronic myeloid leukemia (CML) to live normal life spans but have the potential to impact patients' health-related quality of life (HRQOL). Pat...
Ehab Atallah,Kendra Sweet Ehab Atallah
Purpose of review: Treatment-free remission (TFR) is considered one of the main goals of therapy in patients with CML. Our goal in this paper is to review the current data on TFR, and discuss future directions. ...
Angela Canadeo,Mary Fournogerakis,Felicia Zook Angela Canadeo
Purpose of review: Since the discovery of imatinib, an oral breakpoint cluster region-Abelson murine leukemia tyrosine kinase inhibitor, chronic myelogenous leukemia transformed from a hematologic malignancy primarily tre...
Ahmed Aleem,Ali R Haque,Gregory W Roloff et al. Ahmed Aleem et al.
Purpose of review: Recent efforts to characterize hematologic cancers with genetic and molecular detail have largely relied on mutational profiling via next-generation sequencing (NGS). The application of NGS-guided disea...
Sameh Gaballa,Javier Pinilla-Ibarz Sameh Gaballa
Purpose of review: The treatment landscape of chronic lymphocytic leukemia (CLL) has dramatically changed over the last few years with the introduction of novel targeted agents. Physicians are now faced with several equal...
Tiziano Barbui,Valerio De Stefano Tiziano Barbui
Purpose of review: Coronavirus disease 2019 (COVID-19) is associated with a high rate of respiratory failure, thromboembolism, bleeding, and death. Patients with myeloproliferative neoplasms (MPNs) are prone to both throm...
Aadil Ahmed,Kamran M Mirza,Sanam Loghavi Aadil Ahmed
Purpose of review: Social media-based scientific journal clubs provide an opportunity to promote published literature to a broader audience and allow robust multi-disciplinary and inter-professional discussion. Hematopath...